Can the HPV vaccine protect stem cell transplant patients?
NCT ID NCT03023631
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study tests whether the Gardasil 9 vaccine can help stem cell transplant patients build immunity against HPV. About 48 adults who had a stem cell transplant for blood cancer will receive the vaccine. Researchers will measure antibody levels to see if the vaccine works in these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gardasil 9 (HPV vaccine)
- What this could lead to
- If successful, this could show that the HPV vaccine works in stem cell transplant patients, helping prevent HPV-related cancers in this vulnerable group.
- What could go wrong
- This is a small, single-center study (48 people) with no placebo group. The immune response may be weaker in transplant patients, and the vaccine may not prevent infection or cancer long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer reveal hidden immune clues in tumors?
- A hug in a blanket: could deep pressure calm cancer infusion anxiety?
- Could a strong social circle turn back the clock for transplant survivors?
- Blood test may one day personalize drug dosing after stem cell transplants
- Can a Two-Step stem cell transplant tame Graft-Versus-Host disease?
- Lab-Grown stem cells could speed immune recovery in blood cancer transplants